Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OTHER LONG-TERM ASSETS
Other Long-term Assets HALO - Halozyme Therapeutics, Inc.
17.8 M
LAST VALUE
13.16%
2 YEAR CAGR
32.07%
5 YEAR CAGR
18.82%
10 YEAR CAGR